Introduction
============

γ-glutamyltransferase (GGT) is mostly used in clinical laboratories as a marker of hepatic inflammation. Recently, increasing evidence suggests that GGT plays an important role in the development of cardiovascular events. Longitudinal and cross-sectional investigations have associated GGT with an increase in all-cause mortality, as well as chronic heart diseases such as congestive heart failure ([@b1-mmr-05-04-1092]--[@b5-mmr-05-04-1092]).

The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) ([@b6-mmr-05-04-1092]) defines prehypertension as systolic blood pressure from 120--139 mm/Hg or diastolic pressure from 80--89 mm/Hg. Compared to normotension, prehypertension is associated with a higher risk of developing hypertension ([@b7-mmr-05-04-1092]). Recent studies suggest that baseline GGT may also predict the development of hypertension independent of traditional risk factors. However, these conclusions are based on different study populations, designs and sampling procedures. In addition, the intensity of the association differs between countries and districts ([@b8-mmr-05-04-1092]--[@b14-mmr-05-04-1092]).

In China, hypertension is the leading preventable risk factor for death among adults ([@b15-mmr-05-04-1092]). The aims of this study were to explore a more sensitive risk factor for prehypertension and investigate a new application for GGT. Blood pressure, age, gender and other established risk factors for hypertension were included in analyses and classified into subgroups to observe their interactions. We also defined the association between GGT and the risk of prehypertension.

Materials and methods
=====================

Study population
----------------

The data were part of the Expansion Investigation of Human Physiology Constant in China. This survey was conducted in Harbin and Hailin of Heilongjiang Province, which is located in the northeast of China. Subjects were selected from certain communities using cluster random sampling. The protocol was approved by the Institutional Review Board of the Institute of Basic Medical Science, Chinese Academy of Medical Sciences. All subjects signed written informed consent forms. Inclusion criteria were age between 25 and 80 years, no serious chronic diseases, and no high fever in the past 15 days. Exclusion criteria included hypertension (blood pressure 140/90 mm/Hg or antihypertensive treatment) at baseline and individuals with potential liver pathology.

Measurement
-----------

A precisely designed questionnaire was used to assess demographic data, including date of birth, gender, ethnicity, education level, health status, and health behavior (e.g., smoking, alcohol use and physical activity). All participants were asked to avoid smoking and heavy physical activity for at least 2 h before a physical examination, which included measures of resting blood pressure, height, weight, and waist and hip circumference. Two blood pressure measurements were taken with a mercury sphygmomanometer after participants had rested in a sitting position for at least 5 min. A blood sample was obtained after fasting for 8--12 h. For other biochemical analyses, we collected specimens in a vacuum tube with no additives. Samples were centrifuged at 3000 × g for 10 min at room temperature. After separation, they were measured using a chemistry analyzer (Hitachi 7020) (Hitachi, Tokyo, Japan). Reagents and calibrators were purchased from Hitachi. As part of a chemistry profile, GGT, total cholesterol (TC), glucose, triglycerides (TG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) were measured by kinetic enzyme assays.

Statistical methods
-------------------

Summary statistics are expressed as numbers for categorical data, mean ± SD for approximately continuous variables. Comparison between groups was made using the Chi-square test for categorical data and the Mann-Whitney U test for continuous data.

Multivariable logistic regression analyses were performed to calculate the odds ratios (ORs) for prehypertension according to GGT quartile, adjusting for age, gender, smoking, alcohol consumption, BMI and waist circumference. The P-values quoted are two-sided, and those values with P\<0.05 are regarded as statistically significant. All statistical analysis was performed with SPSS v.13.0 (IBM SPSS Statistics, Armonk, NY, USA).

Results
=======

The baseline characteristics of the study population are summarized by blood pressure in [Table I](#tI-mmr-05-04-1092){ref-type="table"}. A total of 789 males and 1416 females between the ages of 25.0 and 84.6 were included in the study. We excluded 110 individuals with GGT values above the normal reference range of the laboratory (GGT \>67 U/l). The remaining 2,205 participants were included in this analysis. Compared with the normotensive group, those with prehypertension tended to be older and have higher GGT, systolic and diastolic blood pressure, fasting blood glucose, TG and TC. Whereas no significant difference between the two groups was found in mean values of physical activity.

[Table II](#tII-mmr-05-04-1092){ref-type="table"} shows the distribution of the continuous variables across the quartiles of GGT. Significant linear trends were noted across most quartiles with correlations between most variables and GGT (P\<0.01). Notably, ORs of TG, TC, LDL-C, HDL-C were 4.12 (3.36--5.05), 2.00 (1.74--2.29), 2.15 (1.84--2.50) and 4.33 (3.17--5.93), respectively.

[Table III](#tIII-mmr-05-04-1092){ref-type="table"} and [Fig. 1](#f1-mmr-05-04-1092){ref-type="fig"} present adjusted ORs for prehypertension according to GGT quartiles in a series of logistic models. Increased GGT quartiles were positively associated with prehypertension for age, gender, and nationality-adjusted and multivariable-adjusted models. Trends in these associations were also statistically significant. Significant factors in [Table I](#tI-mmr-05-04-1092){ref-type="table"} were included in the models. We examined the soaring ORs of prehypertension associated with increasing levels of serum GGT.

To eliminate confoundings, we stratified the analyses according to drinking status, gender, nationality, glucose and lipid level. [Fig. 2A](#f2-mmr-05-04-1092){ref-type="fig"} shows that the risk of prehypertension increased more rapidly with drinking status, yet there was no linear relationship across GGT quartiles. Stratification by gender produced the same outcome ([Fig. 2B](#f2-mmr-05-04-1092){ref-type="fig"}). Compared with females, males showed a greater trend toward prehypertension (top vs. bottom quartile OR, 2.06; 95% CI, 1.08--3.93). However, the trend was inconsistent within quartiles in males and risk in quartile 2 was lower than that in the other quartiles. The association between GGT and prehypertension within subgroup of nationality was positive in a dose-response pattern, even after full adjustment ([Table IV](#tIV-mmr-05-04-1092){ref-type="table"}, [Fig. 2C](#f2-mmr-05-04-1092){ref-type="fig"}). Adjusted ORs across quartiles of serum GGT in those of Korean nationality were 1.41, 1.43 and 2.12 respectively. In comparison, OR of individuals of Chinese nationality was 0.96, 1.13 and 1.40.

We also examined the impact of glucose on the development of prehypertension according to GGT quartiles. We classified glucose into two groups: normal (glucose \<6.0) and prediabetic status (6.0\< glucose \<7.0). We found a significant linear relationship between GGT quartiles and prehypertension in both states. However, the association was stronger in the prediabetic group than in the normal one, which had an OR of 1.95 (1.06--3.57) in quartile 4 vs. an OR of 1.40 (0.96--2.04) in quartile 1 in the fully adjusted model ([Table IV](#tIV-mmr-05-04-1092){ref-type="table"} and [Fig. 2D](#f2-mmr-05-04-1092){ref-type="fig"}).

According to 'Guide to China\'s Prevention and Treatment of Adult Dyslipidemia', we sorted out two groups, normal level and dyslipidemia (TC \>6.22 or TG \>2.26 or HDL \<1.55 or LDL \>4.14), to highlight the relationship between the indices of lipid metabolism, GGT and prehypertension ([@b16-mmr-05-04-1092]). [Table IV](#tIV-mmr-05-04-1092){ref-type="table"} shows that the association was significant only in the normal group (P\<0.05).

Receiver operating characteristic (ROC) analysis was used to investigate GGT levels and other risk factors associated with prehypertension, and to try to identify the possible dividing line of GGT between healthy subjects and those with prehypertension ([Fig. 3](#f3-mmr-05-04-1092){ref-type="fig"}). The area under the curve (AUC) of GGT was 0.632, slightly higher than AUC of TG (0.630), glucose (0.626), LDL (0.601), HDL (0.559) and TC (0.581). The cutoff point of GGT was 20 IU/l, with a sensitivity of 0.52 and a specificity of 0.67.

Discussion
==========

Several recent studies have identified baseline GGT as an independent biomarker for the development of cardiovascular diseases ([@b1-mmr-05-04-1092]--[@b5-mmr-05-04-1092],[@b8-mmr-05-04-1092]--[@b14-mmr-05-04-1092]). In our study, we found that baseline GGT predicted prehypertension in a dose-response pattern. Adjusted relative risks were 1.13, 1.19 and 1.53 according to quartiles of baseline serum GGT (P\<0.05).

This association was independent of the effects of alcohol consumption and was present in both nondrinkers and drinkers. As serum GGT is also a marker of alcohol intake, these findings are consistent with the hypothesis of an association with prehypertension independent of alcohol intake ([@b2-mmr-05-04-1092],[@b17-mmr-05-04-1092],[@b18-mmr-05-04-1092]). Our outcomes, which show a stronger association among drinkers than nondrinkers, differ somewhat from those in other studies. However, the drinking group did not show a linear tendency across the GGT range. This might be due to our sample size, which precluded meaningful comparisons between lifetime abstainers and former drinkers.

The positive association between GGT and prehypertension was stronger in males. However, the female group showed a direct relation between the quartile of baseline GGT and the risk of prehypertension. Results classified by gender have varied among studies. In a prospective cohort study in Korea with 293 prehypertensive individuals, 5-year hypertension incidence suggested that baseline serum GGT within the normal range strongly predicted the future risk of hypertension, but only in females ([@b8-mmr-05-04-1092]). Our study also differed by sample size and nationalities. The National Health and Nutrition Examination Survey (NHANES) found that among 5,827 US adults, higher serum GGT levels were associated with prehypertension without CVD and hypertension. This association persisted in separate analyses among males and females ([@b19-mmr-05-04-1092]). However, NHANES did not exclude participants with abnormal GGT (GGT \>55 U/l).

We observed a dose-response relationship among Hans and Koreans. Specifically, the association between GGT and prehypertension was stronger in Koreans compared with Hans. Similarly, a study showed that the adjusted relative risks of GGT and prehypertension in Koreans were 1.0, 3.7, 3.6 and 6.0 according to quartiles of baseline serum GGT (P\<0.01) ([@b7-mmr-05-04-1092]). Koreans appear to be at an increased risk for developing hypertension. The reasons are yet to be identified.

Based on our findings, participants with prediabetes and dyslipidemia had higher ORs for prehypertension than those in the normal group. After stratification, only the normal lipid group showed a significant association between GGT and the risk of prehypertension. In the separate logistic regression, the association between GGT and indices of lipids was notable ([@b20-mmr-05-04-1092],[@b21-mmr-05-04-1092]). These outcomes suggest that in healthy subjects, GGT may give a warning for prehypertension before the occurrence of dyslipidemia. A British regional heart study by Wannamethee *et al* noted increasing GGT levels were strongly associated with all-cause mortality, and a strong positive correlation with body mass index, total cholesterol and diabetes mellitus ([@b22-mmr-05-04-1092]). A study reported by Ruttmann *et al* in 2005 with the participation of 163,944 adults also provided similar results revealing that GGT was positively correlated with risk factors for cardiovascular disease including body mass index, serum triglycerides, total cholesterol, systolic and diastolic blood pressure, and glucose. Patients with higher GGT values had a more than 1.5-fold increased risk of total mortality from cardiovascular disease ([@b23-mmr-05-04-1092],[@b24-mmr-05-04-1092]).

GGT is an enzyme that transfers γ-glutamyl functional groups. In relation to cardiovascular disease, GGT falls under a new classification of 'oxidative stress' in view of its role in the degradation of the antioxidant glutathione. Furthermore, GGT hydrolyzes glutathione into glutamate and a cysteinyl-glycine dipeptide, the latter acts as a strong reducing agent of iron, with the stepwise development of the super-oxide ion and hydrogen peroxide. Thus, GGT is involved directly in reactive oxygen species generation as a pro-oxidant ([@b25-mmr-05-04-1092]). GGT could likewise be considered a proinflammatory marker.

We also tried to find the cutoff point for GGT as a tool to assess risk of prehypertension. ROC analysis showed an increased risk of hypertension when GGT exceeded 20 U/l. This is the first report to identify a parameter for discriminating healthy subjects from those at risk of prehypertension. According to our results, GGT was found to be a more valuable biomarker in the diagnosis of prehypertension than glucose, TC, TG, HDL and LDL.

One limitation of our study is its cross-sectional nature, which precludes inferences of causation. This study was conducted in several different districts, and samples were collected at nearly the same time. Although several studies have confirmed that GGT displays a polymorphism ([@b26-mmr-05-04-1092]), we did not provide detection. The strengths of our study included its population-based nature, and stratification and ROC analyses.

In conclusion, GGT within the normal range is associated with prehypertension in China. Thus, GGT may be used to assess cardiovascular risk and plan appropriate treatment. Further study of the mechanisms of GGT as it relates to hypertension may provide a new understanding of how cardiovascular disease develops.
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Comparative ORs of prehypertension according to GGT quartiles by stratification for (A) drinking status, (B) gender, (C) nationality, (D) glucose level and (E) lipid level in fully-adjusted model.
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###### 

Baseline characteristics of participants grouped by blood pressure status.

                                     Normotension (n=1111) mean ± SD   Prehypertension (n=1094) mean ± SD   ^a^P-value   ^b^P-value for trend
  ---------------------------------- --------------------------------- ------------------------------------ ------------ ----------------------
  Age (years)                        43.3±12.2                         51.2±13.5                            \<0.0001     \<0.0001
  Body mass index (kg/m^2^)          22.9±2.9                          24.3±3.0                             \<0.0001     \<0.0001
  Waist circumference (cm)           77.5±8.8                          82.8±9.1                             \<0.0001     \<0.0001
  Hip circumference (cm)             93.2±6.1                          95.3±6.5                             \<0.0001     \<0.0001
  Systolic blood pressure (mm/Hg)    110.1±7.6                         126.7±6.5                            \<0.0001     \<0.0001
  Diastolic blood pressure (mm/Hg)   71.2±6.1                          80.4±6.0                             \<0.0001     \<0.0001
  Fasting plasma glucose (mmol/l)    5.4±1.0                           5.7±1.1                              \<0.0001     \<0.0001
  GGT (U/l)                          19.4±11.4                         24.8±13.7                            \<0.0001     \<0.0001
  Triglycerides (mmol/l)             1.3±0.9                           1.7±1.3                              \<0.0001     \<0.0001
  Total cholesterol (mmol/l)         4.5±0.9                           4.8±0.9                              \<0.0001     \<0.0001
  HDL (mmol/l)                       1.5±0.4                           1.5±0.4                              \<0.0001     \<0.0001
  LDL (mmol/l)                       2.5±0.8                           2.7±0.8                              \<0.0001     \<0.0001

                           n     n     [a](#tfn1-mmr-05-04-1092){ref-type="table-fn"}P-value   [b](#tfn2-mmr-05-04-1092){ref-type="table-fn"}P-value for trend
  ------------------------ ----- ----- ------------------------------------------------------- -----------------------------------------------------------------
  Gender                               \<0.0001                                                \<0.0001
   Male                    298   491                                                           
   Female                  813   603                                                           
  Nationality                          0.006                                                   0.006
   Chinese                 857   801                                                           
   Korean                  209   262                                                           
  Drinking status                      \<0.0001                                                \<0.0001
   Never-drinkers          854   741                                                           
   Current drinkers        203   288                                                           
  Smoking status                       \<0.0001                                                \<0.0001
   Never-smokers           913   802                                                           
   Current smokers         160   23                                                            
  Physical exercise                    0.117                                                   0.195
   Never                   248   283                                                           
   Occasionally            616   566                                                           
   Often                   247   245                                                           
  Education status                     \<0.0001                                                \<0.001
   Less than high school   233   364                                                           
   High school             241   286                                                           
   More than high school   637   444                                                           

P-value for comparison between normotensive and hypertensive participants;

P-value estimated from logistic regression models.

###### 

The distribution of the continuous variables with GGT quartile.

                                     GGT baseline (U/l)                                                                                                                                        
  ---------------------------------- -------------------- ----------------------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------
  Age (years)                        43.8 (13.3)          48.5 (13.4)                                                       49.0 (13.3)                                                        48.5 (13.0)
  OR (95% CI)                        reference            1.03 (1.02--1.04)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.030 (1.02--1.04)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.028 (1.02--1.04)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Body mass index (kg/m^2^)          22.4 (2.8)           23.1 (2.7)                                                        24.1 (3.0)                                                         24.9 (3.1)
  OR (95% CI)                        reference            1.10 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.24 (1.19--1.30)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.355 (1.30--1.42)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Waist circumference (cm)           75.1 (7.9)           78.5 (8.4)                                                        82.1 (8.6)                                                         85.5 (8.8)
  OR (95% CI)                        reference            1.05 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.11 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.16 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Hip circumference (cm)             92.4 (6.0)           93.2 (5.9)                                                        95.2 (6.5)                                                         96.4 (6.3)
  OR (95% CI)                        reference            1.02 (1.00--1.04)[a](#tfn3-mmr-05-04-1092){ref-type="table-fn"}   1.08 (1.06--1.10)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.11 (1.09--1.14)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Systolic blood pressure (mm/Hg)    114.5 (11.5)         118.2 (10.7)                                                      119.8 (10.0)                                                       121.5 (9.9)
  OR (95% CI)                        reference            1.03 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.05 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.06 (1.05--1.15)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Diastolic blood pressure (mm/Hg)   73.5 (8.0)           75.3 (7.3)                                                        76.7 (7.0)                                                         77.7 (7.2)
  OR (95% CI)                        reference            1.03 (1.02--1.05)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   1.06 (1.04--1.08)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.08 (1.06--1.10)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Glucose (mmol/l)                   5.3 (0.9)            5.4 (0.8)                                                         5.6 (1.0)                                                          5.8 (1.4)
  OR (95% CI)                        reference            1.35 (1.13--1.61)[a](#tfn3-mmr-05-04-1092){ref-type="table-fn"}   1.62 (1.37--1.91)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    1.86 (1.58--2.18)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Triglycerides (mmol/l)             1.0 (0.8)            1.3 (0.9)                                                         1.6 (1.2)                                                          1.9 (1.3)
  OR (95% CI)                        reference            2.29 (1.84--2.84)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   3.44 (2.81--4.22)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    4.12 (3.36--5.05)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  Total cholesterol (mmol/l)         4.3 (0.8)            4.6 (0.9)                                                         4.8 (0.9)                                                          4.8 (0.9)
  OR (95% CI)                        reference            1.46 (1.27--1.68)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   2.00 (1.74--2.30)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    2.00 (1.74--2.29)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  HDL (mmol/l)                       1.6 (0.4)            1.4 (0.4)                                                         1.5 (0.4)                                                          1.5 (0.4)
  OR (95% CI)                        reference            1.81 (1.30--2.52)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   2.90 (2.08--4.03)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    4.33 (3.17--5.93)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  LDL (mmol/l)                       2.3 (0.8)            2.5 (0.8)                                                         2.7 (0.8)                                                          2.8 (0.8)
  OR (95% CI)                        reference            1.56 (1.33--1.82)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}   2.02 (1.73--2.36)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}    2.15 (1.84--2.50)[b](#tfn4-mmr-05-04-1092){ref-type="table-fn"}
  GGT (U/l)                          10.4 (2.2)           15.9 (1.4)                                                        22.5 (2.5)                                                         40.2 (10.7)

P\<0.01;

P\<0.001.

###### 

Adjusted ORs of prehypertension according to GGT quartiles.

            OR (95% CI)                                                               
  --------- ------------- ------------------- ------------------- ------------------- ---------
  Model 1   1.0           0.95 (0.75--1.21)   1.21 (0.94--1.55)   1.77 (1.37--2.29)   \<0.001
  Model 2   1.0           1.09 (0.83--1.44)   1.23 (0.93--1.63)   1.66 (1.23--2.23)   0.007
  Model 3   1.0           1.10 (0.83--1.44)   1.21 (0.89--1.58)   1.59 (1.18--2.16)   0.020

Model 1, adjusted for age, gender and nationality; model 2, adjusted as above plus BMI, smoking status, drinking status, waist circumference, hip circumference, education status; model 3, adjusted as above plus glucose, TG, TC, HDL-C, LDL-C.

###### 

Adjusted ORs of prehypertension according to GGT quartiles by stratification for nationality, drinking status, gender, glucose and lipid level.

                           OR (95% CI)                                                               
  ----------------- ------ ------------- ------------------- ------------------- ------------------- -------
  Nationality                                                                                        
   Chinese          1658   1.0           0.96 (0.70--1.33)   1.13 (0.80--1.53)   1.40 (0.99--1.98)   0.141
   Korean           547    1.0           1.41 (0.83--2.40)   1.43 (0.77--2.64)   2.12 (1.05--4.26)   0.209
  Drinking Status                                                                                    
   Drinking         610    1.0           2.10 (0.96--4.63)   1.65 (0.76--3.59)   2.48 (1.12--5.53)   0.102
   Never drinking   1595   1.0           1.03 (0.76--1.38)   1.20 (0.88--1.64)   1.48 (1.05--2.08)   0.115
  Gender                                                                                             
   Male             791    1.0           1.60 (0.81--3.17)   1.40 (0.74--2.65)   2.06 (1.08--3.93)   0.088
   Female           1414   1.0           1.03 (0.76--1.39)   1.22 (0.87--1.71)   1.38 (0.94--2.02)   0.326
  Glucose                                                                                            
   Normal           1607   1.0           1.06 (0.77--1.46)   1.13 (0.80--1.59)   1.40 (0.96--2.04)   0.345
   Prediabetes      598    1.0           1.24 (0.69--2.23)   1.49 (0.83--2.67)   1.95 (1.06--3.57)   0.163
  Lipid level                                                                                        
   Normal           1697   1.0           1.02 (0.76--1.38)   1.13 (0.82--1.56)   1.60 (1.13--2.27)   0.035
   Dyslipidemia     508    1.0           1.53 (0.74--3.17)   1.50 (0.74--3.07)   1.63 (0.78--3.41)   0.599

[^1]: Contributed equally
